These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25288799)

  • 1. New selective peptidyl di(chlorophenyl) phosphonate esters for visualizing and blocking neutrophil proteinase 3 in human diseases.
    Guarino C; Legowska M; Epinette C; Kellenberger C; Dallet-Choisy S; Sieńczyk M; Gabant G; Cadene M; Zoidakis J; Vlahou A; Wysocka M; Marchand-Adam S; Jenne DE; Lesner A; Gauthier F; Korkmaz B
    J Biol Chem; 2014 Nov; 289(46):31777-31791. PubMed ID: 25288799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting the S4-S5 Specificity of Human Neutrophil Proteinase 3 to Improve the Potency of Peptidyl Di(chlorophenyl)-phosphonate Ester Inhibitors: A Kinetic and Molecular Modeling Analysis.
    Guarino C; Gruba N; Grzywa R; Dyguda-Kazimierowicz E; Hamon Y; Łȩgowska M; Skoreński M; Dallet-Choisy S; Marchand-Adam S; Kellenberger C; Jenne DE; Sieńczyk M; Lesner A; Gauthier F; Korkmaz B
    J Med Chem; 2018 Mar; 61(5):1858-1870. PubMed ID: 29442501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substrates.
    Korkmaz B; Attucci S; Hazouard E; Ferrandiere M; Jourdan ML; Brillard-Bourdet M; Juliano L; Gauthier F
    J Biol Chem; 2002 Oct; 277(42):39074-81. PubMed ID: 12114510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate.
    Epinette C; Croix C; Jaquillard L; Marchand-Adam S; Kellenberger C; Lalmanach G; Cadene M; Viaud-Massuard MC; Gauthier F; Korkmaz B
    Biochem Pharmacol; 2012 Mar; 83(6):788-96. PubMed ID: 22209715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors and Antibody Fragments as Potential Anti-Inflammatory Therapeutics Targeting Neutrophil Proteinase 3 in Human Disease.
    Korkmaz B; Lesner A; Guarino C; Wysocka M; Kellenberger C; Watier H; Specks U; Gauthier F; Jenne DE
    Pharmacol Rev; 2016 Jul; 68(3):603-30. PubMed ID: 27329045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A substrate-based approach to convert SerpinB1 into a specific inhibitor of proteinase 3, the Wegener's granulomatosis autoantigen.
    Jégot G; Derache C; Castella S; Lahouassa H; Pitois E; Jourdan ML; Remold-O'Donnell E; Kellenberger C; Gauthier F; Korkmaz B
    FASEB J; 2011 Sep; 25(9):3019-31. PubMed ID: 21670065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and use of highly specific substrates of neutrophil elastase and proteinase 3.
    Korkmaz B; Attucci S; Moreau T; Godat E; Juliano L; Gauthier F
    Am J Respir Cell Mol Biol; 2004 Jun; 30(6):801-7. PubMed ID: 14693667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinase 3 phosphonic inhibitors.
    Grzywa R; Lesner A; Korkmaz B; Sieńczyk M
    Biochimie; 2019 Nov; 166():142-149. PubMed ID: 30876969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis.
    Kantari C; Pederzoli-Ribeil M; Amir-Moazami O; Gausson-Dorey V; Moura IC; Lecomte MC; Benhamou M; Witko-Sarsat V
    Blood; 2007 Dec; 110(12):4086-95. PubMed ID: 17712045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of the mouse model as a therapeutic approach for neutrophil proteinase 3-associated human diseases.
    Korkmaz B; Jenne DE; Gauthier F
    Int Immunopharmacol; 2013 Dec; 17(4):1198-205. PubMed ID: 23886601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of cathepsin C inactivation for membrane exposure of proteinase 3, the target antigen in autoimmune vasculitis.
    Seren S; Rashed Abouzaid M; Eulenberg-Gustavus C; Hirschfeld J; Nasr Soliman H; Jerke U; N'Guessan K; Dallet-Choisy S; Lesner A; Lauritzen C; Schacher B; Eickholz P; Nagy N; Szell M; Croix C; Viaud-Massuard MC; Al Farraj Aldosari A; Ragunatha S; Ibrahim Mostafa M; Giampieri F; Battino M; Cornillier H; Lorette G; Stephan JL; Goizet C; Pedersen J; Gauthier F; Jenne DE; Marchand-Adam S; Chapple IL; Kettritz R; Korkmaz B
    J Biol Chem; 2018 Aug; 293(32):12415-12428. PubMed ID: 29925593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibitors of human neutrophil proteinase 3.
    Korkmaz B; Kellenberger C; Viaud-Massuard MC; Gauthier F
    Curr Pharm Des; 2013; 19(6):966-76. PubMed ID: 23016687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic activity and inhibition of wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils.
    Korkmaz B; Jaillet J; Jourdan ML; Gauthier A; Gauthier F; Attucci S
    J Biol Chem; 2009 Jul; 284(30):19896-902. PubMed ID: 19447886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis).
    Korkmaz B; Lesner A; Letast S; Mahdi YK; Jourdan ML; Dallet-Choisy S; Marchand-Adam S; Kellenberger C; Viaud-Massuard MC; Jenne DE; Gauthier F
    Semin Immunopathol; 2013 Jul; 35(4):411-21. PubMed ID: 23385856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible ketomethylene-based inhibitors of human neutrophil proteinase 3.
    Budnjo A; Narawane S; Grauffel C; Schillinger AS; Fossen T; Reuter N; Haug BE
    J Med Chem; 2014 Nov; 57(22):9396-408. PubMed ID: 25365140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis-induced proteinase 3 membrane expression is independent from degranulation.
    Durant S; Pederzoli M; Lepelletier Y; Canteloup S; Nusbaum P; Lesavre P; Witko-Sarsat V
    J Leukoc Biol; 2004 Jan; 75(1):87-98. PubMed ID: 14525959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generation.
    Grimminger F; Hattar K; Papavassilis C; Temmesfeld B; Csernok E; Gross WL; Seeger W; Sibelius U
    J Exp Med; 1996 Oct; 184(4):1567-72. PubMed ID: 8879231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human oral epithelial cells by neutrophil proteinase 3 through protease-activated receptor-2.
    Uehara A; Sugawara S; Muramoto K; Takada H
    J Immunol; 2002 Oct; 169(8):4594-603. PubMed ID: 12370398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinase 3 Is a Phosphatidylserine-binding Protein That Affects the Production and Function of Microvesicles.
    Martin KR; Kantari-Mimoun C; Yin M; Pederzoli-Ribeil M; Angelot-Delettre F; Ceroi A; Grauffel C; Benhamou M; Reuter N; Saas P; Frachet P; Boulanger CM; Witko-Sarsat V
    J Biol Chem; 2016 May; 291(20):10476-89. PubMed ID: 26961880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteinase-3 induces procaspase-3 activation in the absence of apoptosis: potential role of this compartmentalized activation of membrane-associated procaspase-3 in neutrophils.
    Pederzoli M; Kantari C; Gausson V; Moriceau S; Witko-Sarsat V
    J Immunol; 2005 May; 174(10):6381-90. PubMed ID: 15879139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.